07/07/2018 12:30:00

Restoration Robotics™ Unveils ARTAS® iX, the Most Advanced Robotic Hair Restoration System, At The Aesthetic Show™ 2018

Presentations by CEO and COO draw attention and enthusiasm by attendees

Launch marks pivotal moment in hair restoration

SAN JOSE, Calif., July 07, 2018 (GLOBE NEWSWIRE) --  Restoration Robotics, Inc. (NASDAQ:HAIR), the global leader in robotic hair restoration, today provided an update from The Aesthetic Show™ 2018 where the Company unveiled its new ARTAS® iX Robotic Hair Restoration System during a mainstage presentation and a pre-show educational session to attendees. The ARTAS iX Robotic Hair Restoration System is the first and only robotic intelligent solution to offer precise, minimally invasive, repeatable harvesting and implantation functionality in one platform.

Ryan Rhodes, Chief Executive Officer of Restoration Robotics, unveiled the new ARTAS iX System and the opportunity it presents to aesthetic physicians during a presentation to a full room of attendees on Friday, July 6th on the Main Stage in the Exhibit Hall.

Gabe Zingaretti, Dott. Ing., Chief Operations Officer of Restoration Robotics, presented an overview of the ARTAS iX System and its new capabilities to attendees on Thursday, July 5th in a Pre-Show Educational Session titled “The Art of Male Aesthetics Symposium.”

Ryan Rhodes commented, “Worldwide, approximately 1.2 billion men suffer from hereditary baldnessi,ii and there is a growing demand for less invasive hair restoration proceduresiii. We have the most advanced robotic technology and now are taking hair restoration to a higher level with the robotic implantation fuctionality. We believe the introduction of the ARTAS iX System is a pivotal moment for Restoration Robotics and the positive reaction and enthusiasm expressed by attendees at The Aesthetic Show is certainly encouraging.”

Dr. Zingaretti added, “Restoration Robotics has been pioneering robotic hair restoration for more than a decade. The ARTAS iX System is the culmination of over three years of research, engineering and clinical  development based on input from leading hair restoration surgeons and our valued customers. We responded with the ARTAS iX System: a complete solution that integrates graft harvesting, simultaneous recipient site-making and implantation.” 

The Aesthetic Show™ 2018 is being held July 5-8 at The Wynn Hotel in Las Vegas, NV. For more information on the ARTAS iX Robotic Hair Restoration System visit www.artashair.com/ix/physicians.

About Restoration Robotics

Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS™ Robotic Hair Restoration System. The ARTAS System is the first and only physician-assisted system to dissect and assist in the harvesting of follicular units directly from the scalp, create recipient implant sites using proprietary algorithms and now implant the hair follicles into the designated sites. The Company has unique expertise in machine vision, image guidance, visual servoing and robotics, as well as developing intuitive interfaces to manage these technologies.

Forward-looking Statements

Statements made in this press release that are not statements of historical fact are forward-looking statements. Forward-looking statements are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are commonly identified by words such as “would,” “may,” “expects,” “believes,” “plans,” “intends,” “projects” and other terms with similar meaning. Investors are cautioned that the forward-looking statements in this press release are based on current beliefs, assumptions and expectations, speak only as of the date of this document and involve risks and uncertainties that could cause actual results to differ materially from current expectations. Such statements are subject to certain known and unknown risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results and other future events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements.  These statements include, without limitation, the following: our expectations for the global male hair restoration market; our expectations regarding the ability of ARTAS iX to deliver outstanding results and reduce clinical fatigue; whether there is growth in demand for our ARTAS System; the progress of our commercialization, marketing and manufacturing capabilities; the continuing productivity and effectiveness of our commercial infrastructure and salesforce; our expectations regarding the potential market size and the size of the patient populations for ARTAS being accurate; and whether we are effective in the pricing of ARTAS iX. Material factors that could cause actual results to differ materially from current expectations are described in greater detail in our Annual Report on Form 10-K filed on March 5, 2018, as well as any reports that we may file with the SEC in the future. These factors may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our forward-looking statements. We expressly disclaim any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

Media Contact

Lisa Markle

Director of Marketing

Restoration Robotics, Inc.

+1-408-883-6764

lisam@restorationrobotics.com

Investor Contact

The Ruth Group

Lee Roth & Brian Johnston

ir@restorationrobotics.com

646-536-7000

i

https://www.americanhairloss.org/men_hair_loss/

ii

https://www.reference.com/world-view/many-men-world-8e066f56a72027ce?qo=cdpArticles

iii *ISHRS 2017 Practice Census Results

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
19 Sep
 
Jeg har været med som skribent her på EI siden 2012 og jeg har haft mange gode øjeblikke ved at være..
62
20 Sep
VWS
Vestas aktien fylder en del i min portefølje, hvorfor jeg følger den tæt. Jeg var dog selv tidligere..
32
16 Sep
OMXC25
Putin kan lukke samtlige banker i Europa blot ved at sende nogle penge igennem dem, og bagefter lækk..
29
18 Sep
BIOPOR
BioPorto - InvestorDagen 18.september 2018 Jeg deltog til præsentationen af BioPorto ved CFO Ole ..
24
20 Sep
 
Danmark forærer 12mia kr væk til svindlere - med hjælp fra et par fordrukne ansatte i skat. Så stort..
20
18 Sep
PNDORA
.....lyder ikke for klogt. Nu har vi været under pres fra shortere i lang tid i Pandora som fik bank..
20
20 Sep
DANSKE
Erhversministeren mener at hvidvaskskandalen er "en af de største skandaler i danmarkshistorien" og ..
16
15 Sep
DANSKE
...og jeg kan supplere, man skal ikke tro på mennesker der er maniske eller totalt besatte af en giv..
16
16 Sep
BAVA
Bava var sat op til en næsten perfekt IHS, der ville sende den op i ca. 225.   Men så kommer der lig..
14
20 Sep
PNDORA
Til jer der foelger Pandopra smider jeg lige et link til en god Forbesartikel der giver et godt indt..
13

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)
2
The observation status for Skånska Energi AB is updated (344/18)
3
Carlyle Announces Pricing the Tender Offer for up to $250 Million 3.875% Senior Notes due 2023
4
AMG Advanced Metallurgical Group N.V. Completes Multi-Year Agreement for 100% Renewable Energy Contract for UK Operations
5
Precipio Enters into Exchange Agreement to Restructure Remaining Legacy Accounts Payable for approximately 20% of Original ~$5M

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 September 2018 05:05:20
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB6 - 2018-09-22 06:05:20 - 2018-09-22 05:05:20 - 1000 - Website: OKAY